Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Transgene
  6. News
  7. Most relevant
    TNG   FR0005175080

TRANSGENE

(TNG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about TRANSGENE
10/01BIOINVENT INTERNATIONAL : and Transgene to present preclinical data on BT-001 oncolytic vi..
AQ
10/01Transgene and BioInvent to Present Preclinical Data on BT-001 Oncolytic Virus at SITC 2..
CI
09/23Certain Ordinary Shares of Transgene SA are subject to a Lock-Up Agreement Ending on 23..
CI
09/16TRANSGENE : Gastrointestinal Cancer Drug Study Confirms Potential of Cancer-Killing Virus
MT
09/16Transgene Presents Data from Phase I Clinical Trial Confirming the Potential of the Onc..
CI
09/13GLOBAL MARKETS LIVE : Valneva, Walt Disney, ViacomCBS, General Motors, Amazon...
09/07PRESS RELEASE : CEVEC and UCB sign agreement for the use of CEVEC's ELEVECTA(R) AAV manufa..
DJ
09/02GLOBAL MARKETS LIVE : Ford, Walmart, Apple, Volkswagen, Tesla...
09/01Transgene Participates in New Cancer Research Consortium
CI
06/28Transgene Announces Update on Phase I Clinical Trial of TG4050
CI
06/25GLOBAL MARKETS LIVE : Facebook, Toshiba, Fedex, Nike, Microsoft...
06/24Transgene announces First Patient Enrolled in Expanded Phase II Clinical Trial of Tg400..
CI
06/22GLOBAL MARKETS LIVE : Netflix, Boeing, Tesla, Delta Air Lines, Blackstone Resources....
06/22TRANSGENE : Raises $40.6 Million in Share Sale; Stock Falls 7%
MT
06/08Transgene Strengthens Global IP Protection for its Novel Invir.IOÖ Oncolytic Viruses En..
CI
05/27BioInvent, Transgene Win US FDA Nod For Phase 1/2a Study of Cancer Vaccine
MT
05/27BIOINVENT INTERNATIONAL : and Transgene receive IND approval from the U.S. FDA for BT-001,..
AQ
05/27Bioinvent International AB and Transgene Receive IND Approval from the U.S. FDA for BT-..
CI
04/28Global markets live: Microsoft, Apple, Tesla...
04/27TRANSGENE : April 27, 2021 - Transgene reports business update and end Q1 2021 financial p..
PU
04/27LogicBio announces clinical and corporate updates
DJ
04/12TRANSGENE : April 12, 2021 - Transgene Announces Upcoming Investor Meetings
PU
04/09TRANSGENE : April 9, 2021 - Transgene presents initial Phase I data of TG6002, highlightin..
PU
04/09Transgene Presents Initial Phase I Data of TG6002, Highlighting the Potential of the In..
CI
04/07TRANSGENE : April 7, 2021 - Availability of Preparatory Documents for the Combined General..
PU
04/01TRANSGENE : April 1, 2021 - Availability of Transgene's 2020 Universal Registration Docume..
PU
03/30SGS : to Support Selecta Biosciences, AskBio's Phase One Trial for Genetic Disorder Treatm..
MT
03/18PRESS RELEASE : Antion Biosciences Launches Novel Cell and Gene-engineering Platform, miCA..
DJ
03/17TRANSGENE BIOTEK : in Pact to Provide Oral, Nasal Formulations for COVID-19 Vaccine
MT
03/10TRANSGENE : Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination W..
BU
03/10TRANSGENE : Significant Milestones Achieved on All Drug Candidates in 2020 and Financial V..
BU
03/10Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination ..
CI
03/10Transgene Sa Reports Earnings Results for the Full Year Ended December 31, 2020
CI
03/10Transgene SA Develops Individualized Immunotherapy Based on Multiple Advanced Genetic E..
CI
03/09TRANSGENE : March 10, 2021 - Transgene expands Phase II clinical trial of therapeutic vacc..
PU
03/09TRANSGENE : March 10, 2021 - Significant milestones achieved on all drug candidates in 202..
PU
03/02TRANSGENE : to Present Its Immuno-Oncology Expertise at Upcoming Scientific Conferences
BU
03/01TRANSGENE : March 2, 2021 - Transgene to Present its Immuno-Oncology Expertise at Upcoming..
PU
03/01TRANSGENE : BioInvent Enroll First Patient In Oncolytic Vaccinia Virus Trial
MT
03/01BIOINVENT INTERNATIONAL : and Transgene has enrolled first patient in Phase I/IIa trial of..
AQ
03/01TRANSGENE : and BioInvent Have Enrolled First Patient in Phase I/IIa Trial of Novel Oncoly..
BU
03/01Transgene and BioInvent International AB Enroll First Patient in Phase I/IIa Trial of N..
CI
01/21TRANSGENE : Up 21% as First Patient Dosed with Head, Neck Cancer Treatment
MT
01/21TRANSGENE : January 21, 2021 - First Head & Neck Cancer Patient Treated in France in a Pha..
PU
01/21TRANSGENE : First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4..
BU
01/21Transgene SA Announces the First Head & Neck Cancer Patient Treated in France in a Phas..
CI
01/19TRANSGENE : January 19, 2021 - Transgene and BioInvent receive approval from ANSM to proce..
PU
01/19TRANSGENE : and BioInvent Receive Approval From ANSM to Proceed With Phase I/IIa Trial of ..
BU
01/19Transgene Sa and Bioinvent Receive Approval from Ansm to Proceed with Phase I/Iia Trial..
CI
01/15TRANSGENE : January 14, 2021 - Transgene Appoints Gaëlle Stadtler as Director of Human Res..
PU
01/14TRANSGENE : Appoints Gaëlle Stadtler as Director of Human Resources
BU
01/14Transgene Appoints Gaëlle Stadtler as Director of Human Resources
CI
01/06TRANSGENE : at June 30, 2020
PU
01/06TRANSGENE : Report on the Transgene Liquidity Contract with Natixis Oddo BHF SCA as of Dec..
BU
2020TRANSGENE : December 21, 2020 - Transgene and BioInvent receive CTA approval for Phase 1/2..
PU
2020TRANSGENE : and BioInvent Receive CTA Approval for Phase 1/2a Trial of Oncolytic Virus BT-..
BU
2020Transgene and BioInvent Receive CTA Approval for Phase 1/2a Trial of Oncolytic Virus BT..
CI
2020TRANSGENE : Announces Financial Calendar for 2021
BU
2020TRANSGENE : December 16, 2020 - Transgene Announces Investor Meetings for January 2021
PU
2020TRANSGENE : Announces Investor Meetings for January 2021
BU
2020TRANSGENE : December 3, 2020 - Transgene to present Phase 1b/2 trial results of TG4001 in ..
PU
2020TRANSGENE : to Present Phase 1b/2 Trial Results of TG4001 in Combination with avelumab in ..
BU
2020TRANSGENE : December 3, 2020 - Transgene appoints Hedi Ben Brahim as Chairman and Chief Ex..
PU
2020TRANSGENE : Appoints Hedi Ben Brahim as Chairman and Chief Executive Officer
BU
2020Transgene Announces Management Changes
CI
2020Transgene Appoints Hedi Ben Brahim as Chief Executive Officer, Effective January 1, 202..
CI
2020TRANSGENE : And BioInvent Present Data on Next Generation Oncolytic Virus BT-001 at the SI..
BU
2020TRANSGENE : November 9, 2020 - Transgene presents e-poster outlining detailed results from..
PU
2020TRANSGENE : Presents E-Poster Outlining Detailed Results from the Phase 1b/2 Trial of TG40..
BU
2020Transgene SA Announces the Presentation of the Detailed Results from the Phase 1b/2 Tri..
CI
2020Bioinvent International AB and Transgene Present Data on Next Generation Oncolytic Viru..
CI
2020TRANSGENE : November 5, 2020 - Transgene reports business update and end Q3 2020 financial..
PU
2020TRANSGENE : Reports Business Update and End Q3 2020 Financial Position
BU
2020TRANSGENE : Presents Its Individualized Immunotherapy, TG4050, at The Annual Neoantigen Ba..
BU
2020TRANSGENE : October 27, 2020 - Transgene announces detailed results from clinical study of..
PU
1  2  3  4  5Next
Upcoming event on TRANSGENE